Journal of Cancer Research and Clinical Oncology

, Volume 137, Issue 4, pp 651–658

Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection

  • Dan-Dan Wang
  • Yi-Ming Zhao
  • Lu Wang
  • Guang Ren
  • Fei Wang
  • Zu-Guang Xia
  • Xi-Long Wang
  • Tao Zhang
  • Qi Pan
  • Zhi Dai
  • Ju-Ping Chen
  • Hai-Yan Dai
  • Wei Zhang
  • Hong-Wei He
  • Jia-Min Zhou
  • Guang-Yu Tang
  • Jian Zhou
  • Jia Fan
  • Zhao-You Tang
Original Paper

Abstract

Purpose

Metabolic syndrome and insulin resistance have been linked to increased risk of occurrence and mortality of hepatocellular carcinoma (HCC). Recently, retinol-binding protein 4 (RBP4) was clarified as a specific serological marker of insulin resistance. The aim of this study was to determine whether serum RBP4 could be used as a potential marker for predicting prognosis in patients with HCC after curative resection.

Methods

Western immunoblotting and Enzyme-linked immunosorbent assay were used to measure the RBP4 expression in cell lines, supernatant, and serum. Serum RBP4 levels were compared with clinicopathological features and outcomes of patients with HCC. Furthermore, we investigated the impact of serum RBP4 level, serum C-peptide level, and HOMA-IR on overall survival (OS) and disease-free survival (DFS) of patients with HCC in the training cohort (156 patients with HCC), and then were validated in the validation cohort (105 patients with HCC).

Results

RBP4 protein overexpressed in HCC cell lines compared with normal liver cell line (P < 0.001) and correlated with metastatic potential. Serum RBP4 levels were associated with OS [hazard ratio (HR) = 2.208, P < 0.001] and DFS (HR = 1.878, P = 0.029) of patients with HCC. By multivariate analysis, the serum RBP4 level was identified as an independent factor for OS (HR = 2.170, P = 0.004) and DFS (HR = 1.769, P = 0.037) of patients with HCC. The prognostic value of serum RBP4 level was confirmed in the validation cohort.

Conclusions

The serum RBP4 level is potential to be a useful prognostic factor for HCC after curative resection.

Keywords

Retinol-binding protein Hepatocellular carcinoma Serum Prognosis 

Supplementary material

432_2010_927_MOESM1_ESM.docx (15 kb)
Supplementary material 1 (DOCX 15 kb)
432_2010_927_MOESM2_ESM.tif (1 mb)
Supplemental Fig. S1 In training cohort, Stratified survival curve were drawn according to absence or presence of liver cirrhosis (A-D) and TNM stage (E-H) to further investigate the prognostic value of serum RBP4 in HCC patients (TIFF 1048 kb)
432_2010_927_MOESM3_ESM.tif (262 kb)
Supplemental Fig. S2 With the cutoff used in training cohort, prognostic significance of serum RBP4 level for OS (A) and DFS (B) were confirmed in the validation cohort (TIFF 262 kb)

References

  1. Bruce WR, Giacca A, Medline A (2000) Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9:1271–1279PubMedGoogle Scholar
  2. Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK (2004) Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127:1044–1050CrossRefGoogle Scholar
  3. Deng ZB, Poliakov A, Hardy RW, Clements R, Liu C, Liu Y, Wang J, Xiang X, Zhang S, Zhuang X, Shah SV, Sun D, Michalek S, Grizzle WE, Garvey T, Mobley J, Zhang HG (2009) Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58:2498–2505PubMedCrossRefGoogle Scholar
  4. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51PubMedCrossRefGoogle Scholar
  5. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2005) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552–2563CrossRefGoogle Scholar
  6. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM, Jordan J (2004) Retinol-binding protein 4 in human obesity. Diabetes 55:2805–2810CrossRefGoogle Scholar
  7. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E (2000) Serum C-peptide, IGF-I, IGFBPs, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592–1600PubMedCrossRefGoogle Scholar
  8. Kinoshita M, Miyata M (2002) Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 36:433–438PubMedCrossRefGoogle Scholar
  9. Li LD, Zhang SW, Lu FZ (1997) Research on characteristics of mortality spectrum and type composition of malignant tumors in China. Chin J Oncol 19:323–328 (in Chinese)Google Scholar
  10. Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL, Liu YK, Tang ZY (2004) Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 130:460–468PubMedCrossRefGoogle Scholar
  11. Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL (2009) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137:482–488PubMedCrossRefGoogle Scholar
  12. Miuma S, Ichikawa T, Taura N, Shibata H, Takeshita S, Akiyama M, Motoyoshi Y, Ozawa E, Fujimoto M, Kawashimo H, Miyaaki H, Eguchi K, Nakao K (2009) The level of fasting serum insulin, but not adiponectin, is associated with the prognosis of early stage hepatocellular carcinoma. Oncol Rep 22:1415–1424PubMedCrossRefGoogle Scholar
  13. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRefGoogle Scholar
  14. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238PubMedCrossRefGoogle Scholar
  15. Petta S, Cammà C, Di Marco V, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Craxì A (2008) Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with HCV genotype 1. Hepatology 48:28–37PubMedCrossRefGoogle Scholar
  16. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, Wong J (2002) Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20:1775–1785PubMedCrossRefGoogle Scholar
  17. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU (2007) High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30:1173–1178PubMedCrossRefGoogle Scholar
  18. Sun FX, Tang ZY, Lui KD, Ye SL, Xue Q, Gao DM, Ma ZC (1996) Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer 66:239–243PubMedCrossRefGoogle Scholar
  19. Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47:684–690PubMedCrossRefGoogle Scholar
  20. Tang ZY (2005) Hepatocellular carcinoma surgery–review of the past and prospects for the 21st century. J Surg Oncol 91:95–96PubMedCrossRefGoogle Scholar
  21. Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expression of the factors associated with metastasis. Br J Cancer 81:814–821PubMedCrossRefGoogle Scholar
  22. Van Dam RM, Hu FB (2007) Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? Clin Chem 53:5–7PubMedGoogle Scholar
  23. Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Ocol 27:176–185CrossRefGoogle Scholar
  24. Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F (2007) Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30:1168–1172PubMedCrossRefGoogle Scholar
  25. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356–362PubMedCrossRefGoogle Scholar
  26. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92:2590–2597PubMedCrossRefGoogle Scholar
  27. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, Sun HC (2008) High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26:2707–2716PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Dan-Dan Wang
    • 1
  • Yi-Ming Zhao
    • 8
  • Lu Wang
    • 8
  • Guang Ren
    • 3
  • Fei Wang
    • 6
  • Zu-Guang Xia
    • 4
  • Xi-Long Wang
    • 8
  • Tao Zhang
    • 5
  • Qi Pan
    • 8
  • Zhi Dai
    • 8
  • Ju-Ping Chen
    • 1
  • Hai-Yan Dai
    • 2
  • Wei Zhang
    • 7
  • Hong-Wei He
    • 8
  • Jia-Min Zhou
    • 8
  • Guang-Yu Tang
    • 6
  • Jian Zhou
    • 8
  • Jia Fan
    • 8
  • Zhao-You Tang
    • 8
  1. 1.Department of EndocrinologyPunan HospitalShanghaiChina
  2. 2.Department of Gynecology and ObstetricsPunan HospitalShanghaiChina
  3. 3.Department of RadiologyHuashan Hospital, Fudan UniversityShanghaiChina
  4. 4.Department of HematologyNinth People’s Hospital, Shanghai Jiaotong University School of MedicineShanghaiChina
  5. 5.Department of RadiologySecond Affiliated Hospital, Xuzhou Medical CollegeXuzhouChina
  6. 6.Department of RadiologyTenth People’s Hospital, Tongji UniversityShanghaiChina
  7. 7.Gynecology and Obstetrics Institute, Gynecology and Obstetrics HospitalFudan UniversityShanghaiChina
  8. 8.Liver Cancer Institute, Zhongshan HospitalFudan UniversityShanghaiChina

Personalised recommendations